Abstract

BackgroundExpression of autonomous bioluminescence from human cells was previously reported to be impossible, suggesting that all bioluminescent-based mammalian reporter systems must therefore require application of a potentially influential chemical substrate. While this was disproven when the bacterial luciferase (lux) cassette was demonstrated to function in a human cell, its expression required multiple genetic constructs, was functional in only a single cell type, and generated a significantly reduced signal compared to substrate-requiring systems. Here we investigate the use of a humanized, viral 2A-linked lux genetic architecture for the efficient introduction of an autobioluminescent phenotype across a variety of human cell lines.Methodology/Principal FindingsThe lux cassette was codon optimized and assembled into a synthetic human expression operon using viral 2A elements as linker regions. Human kidney, breast cancer, and colorectal cancer cell lines were both transiently and stably transfected with the humanized operon and the resulting autobioluminescent phenotype was evaluated using common imaging instrumentation. Autobioluminescent cells were screened for cytotoxic effects resulting from lux expression and their utility as bioreporters was evaluated through the demonstration of repeated monitoring of single populations over a prolonged period using both a modified E-SCREEN assay for estrogen detection and a classical cytotoxic compound detection assay for the antibiotic Zeocin. Furthermore, the use of self-directed bioluminescent initiation in response to target detection was assessed to determine its amenability towards deployment as fully autonomous sensors. In all cases, bioluminescent measurements were supported with traditional genetic and transcriptomic evaluations.Conclusions/SignificanceOur results demonstrate that the viral 2A-linked, humanized lux genetic architecture successfully produced autobioluminescent phenotypes in all cell lines tested without the induction of cytotoxicity. This autobioluminescent phenotype allowed for repeated interrogation of populations and self-directed control of bioluminescent activation with detection limits and EC50 values similar to traditional reporter systems, making the autobioluminescent cells amenable to automated monitoring and significantly reducing the time and cost required to perform bioluminescent workflows.

Highlights

  • The use of high signal to noise bioluminescent sensor technology is quickly replacing traditional fluorescent sensor technologies for research and pre-clinical applications

  • Conclusions/Significance: Our results demonstrate that the viral 2A-linked, humanized lux genetic architecture successfully produced autobioluminescent phenotypes in all cell lines tested without the induction of cytotoxicity

  • We have focused on the development of the bacterial luciferase sensor system, as it is the only known bioluminescent system capable of autonomously producing both its luciferase and associated luciferin generating protein products without exogenous investigator interaction

Read more

Summary

Introduction

The use of high signal to noise bioluminescent sensor technology is quickly replacing traditional fluorescent sensor technologies for research and pre-clinical applications. Despite improvements over the last decade that have enhanced luc gene expression [3], or the introduction of functioning Renilla (introduced in 1991) [4] and Gaussia (introduced in 2002) [5] luciferase sensor systems, these technologies remain limited due to their requisite administration of a light activating chemical substrate (luciferin) that must be repeatedly purchased, is sensitive to light, oxygen, high pH exposure, or repeated freeze/thaw cycles, and, when applied concurrent with cellular lysis as is common in most commercial luciferase assay kits, yields only single time point data For these reasons, we have focused on the development of the bacterial luciferase (lux) sensor system, as it is the only known bioluminescent system capable of autonomously producing both its luciferase and associated luciferin generating protein products without exogenous investigator interaction. We investigate the use of a humanized, viral 2A-linked lux genetic architecture for the efficient introduction of an autobioluminescent phenotype across a variety of human cell lines

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call